Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid

Journal of the American Academy of Dermatology

Volumn 40, Issue 5 I, 1999, Pages 741-749

  Heilborn, J D ^a   Stahle Backdahl, M ^a   Albertioni, F ^a   Vassilaki, I ^a   Peterson, C ^a   Stephansson, E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

7 HYDROXYMETHOTREXATE; BETAMETHASONE DIPROPIONATE; METHOTREXATE; PREDNISONE;

AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFICACY; ELDERLY CARE; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; MALE; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PEMPHIGOID; PRIORITY JOURNAL; REMISSION; STEROID THERAPY;

EID: 0032947756     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70156-8     Document Type: Article

References (24)

1. NJ Korman Bullous pemphigoid Dermatol Clin 11 1993 483 498
2. LH Morrison LA Diaz GJ Anhalt Bullous pemphigoid 1st ed F Wojnarowska RA Briggaman Management of blistering diseases 1990 Chapman and Hall Ltd London 63 82
3. VA Venning F Wojnarowska Lack of predictive factors for the clinical course of bullous pemphigoid J Am Acad Dermatol 26 1992 585 589
4. MA Paul JL Jorizzo AB Fleischer Jr WL White Low-dose methotrexate treatment in elderly patients with bullous pemphigoid J Am Acad Dermatol 31 1994 620 625
5. M Ståhle-Bäckdahl M Inoue GJ Giudice 92-kD Gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid auotoantigen J Clin Invest 93 1994 2022 2030
6. AR Ahmed JC Maize TT Provost Bullous pemphigoid: clinical and immunologic follow-up after successful treatment Arch Dermatol 113 1977 1043 1046
7. TT Provost JC Maize AR Ahmed Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid Arch Dermatol 115 1979 156 160
8. TF Downham TA Chapel Bullous pemphigoid: therapy in patients with and without diabetes mellitus Arch Dermatol 114 1978 639 642
9. EA Olsen The pharmacology of methotrexate J Am Acad Dermatol 25 1991 306 318
10. HH Roenigk R Auerbach HI Maibach Methotrexate guidelines—revised J Am Acad Dermatol 6 1982 145 155
11. HJ Williams RF Willkens CO Samuelsson Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis Arthritis Rheum 28 1985 721 730
12. AL Metzger A Bohan LS Goldberg Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy Ann Intern Med 81 1974 182 189
13. U Kiistala KK Mustakallio In-vivo separation of epidermis by production of suction blisters Lancet 1 1964 1444 1445
14. U Kiistala KK Mustakallio Dermo-epidermal separation with suction J Invest Dermatol 48 1967 466 477
15. F Albertioni B Petersson O Beck Simultaneous quantification of methotrexate and its two main metabolites in biological fluids by a novel solid-phase extraction procedure using high-performance liquid chromatography J Chromatogr B: Biomed Appl 665 1995 163 170
16. FM Balis JL Savitch WA Bleyer Pharmacokinetics of oral methotrexate in children Cancer Res 43 1983 2342 2345
17. D Oguey F Kölliker NJ Gerber J Reichen Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis Arthritis Rheum 35 1992 611 614
18. SA Jacobs RG Stoller BA Chabner 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate J Clin Invest 57 1978 534 538
19. D Farquhar T Loo S Vadlamudi Synthesis and biological evaluation of 7-hydroxymethotrexate J Med Chem 15 1972 567 569
20. P Bernard J Venot F Constant Blood eosinophilia as a severity marker for bullous pemphigoid J Am Acad Dermatol 16 1987 879 881
21. BJ Liddle Methotrexate interactions Clin Exp Dermatol 16 1991 311 312
22. BN Cronstein D Naime E Ostad The antiinflammatory mechanism of methotrexate J Clin Invest 92 1993 2675 2682
23. CJ McDonald Cytotoxic agents for use in dermatology, I J Am Acad Dermatol 12 1985 753 775
24. P Bernard C Bedane J-M Bonnetblanc Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients Br J Dermatol 136 1997 694 698